RxSight Class Action Lawsuit: Deadline to Join on Sept. 22, 2025.

Rosen Law Firm reminds investors of RxSight securities purchased between May 7, 2024 and July 8, 2025 to join the class action by September 22, 2025. A lead plaintiff must be appointed by the court. Investors may be entitled to compensation without payment of out-of-pocket fees or costs through a contingency fee arrangement. Contact Phillip Kim, Esq. at 866-767-3653 or [email protected] for more information.

Investors who purchased shares of RxSight, Inc. (NASDAQ: RXST) between May 7, 2024 and July 8, 2025 are encouraged to join a securities fraud class action lawsuit. The deadline to participate is September 22, 2025, and a lead plaintiff must be appointed by the court.

The lawsuit alleges that during the class period, Defendants made materially false and/or misleading statements and/or failed to disclose significant issues affecting the company's business. Specifically, the complaint alleges that:
1. The company was experiencing "adoption challenges" and/or structural issues resulting in declines in sales and utilization.
2. Defendants had overstated the demand for RxSight's products.
3. As a result, RxSight was unlikely to meet its own previously issued financial guidance for fiscal year 2025.
4. Defendants' positive statements about the company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Investors who wish to participate in the class action can contact Phillip Kim, Esq. at 866-767-3653 or [email protected] for more information. There is no cost to join the class action, and investors may be entitled to compensation without payment of out-of-pocket fees or costs through a contingency fee arrangement.